Search Results - "Rajeev Krishnan, Sabna"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Liquid Biopsies in Cancer Diagnosis, Monitoring, and Prognosis by De Rubis, Gabriele, Rajeev Krishnan, Sabna, Bebawy, Mary

    “…Liquid biopsies, comprising the noninvasive analysis of circulating tumor-derived material (the ‘tumor circulome’), represent an innovative tool in precision…”
    Get full text
    Journal Article
  2. 2

    Circulating tumor DNA – Current state of play and future perspectives by De Rubis, Gabriele, Krishnan, Sabna Rajeev, Bebawy, Mary

    Published in Pharmacological research (01-10-2018)
    “…[Display omitted] Cancer management paradigms are shifting towards a personalized approach thanks to the advent of the -omics technologies. Liquid biopsies,…”
    Get full text
    Journal Article
  3. 3

    Isolation of Human CD138+ Microparticles from the Plasma of Patients with Multiple Myeloma by Krishnan, Sabna Rajeev, Luk, Frederick, Brown, Ross D, Suen, Hayley, Kwan, Yiulam, Bebawy, Mary

    Published in Neoplasia (New York, N.Y.) (01-01-2016)
    “…The confinement of multiple myeloma (MM) to the bone marrow microenvironment requires an invasive bone marrow biopsy to monitor the malignant compartment. The…”
    Get full text
    Journal Article
  4. 4

    Multiple myeloma and persistence of drug resistance in the age of novel drugs (Review) by KRISHNAN, SABNA RAJEEV, JAISWAL, RITU, BROWN, ROSS D, LUK, FREDERICK, BEBAWY, MARY

    Published in International journal of oncology (01-07-2016)
    “…Multiple myeloma (MM) is a mature B cell neoplasm that results in multi-organ failure. The median age of onset, diverse clinical manifestations, heterogeneous…”
    Get full text
    Journal Article
  5. 5

    A liquid biopsy to detect multidrug resistance and disease burden in multiple myeloma by Rajeev Krishnan, Sabna, De Rubis, Gabriele, Suen, Hayley, Joshua, Douglas, Lam Kwan, Yiu, Bebawy, Mary

    Published in Blood cancer journal (New York) (13-03-2020)
    “…Multiple myeloma is an incurable cancer of bone marrow plasma cells, with a 5-year survival rate of 43%. Its incidence has increased by 126% since 1990…”
    Get full text
    Journal Article
  6. 6

    Abstract B45: Multiple myeloma: A novel tailor-made therapeutic management by Krishnan, Sabna Rajeev, Bebawy, Mary, Luk, Frederick, Brown, Ross Duncan, Kwan, Yiu Lam

    Published in Clinical cancer research (01-09-2015)
    “…Abstract Introduction: Multiple Myeloma (MM) is an incurable hematological malignancy affecting plasma cells marked by highly heterogeneous survival rate…”
    Get full text
    Journal Article
  7. 7

    Abstract 5306: Microparticles as novel prognostic markers in multiple myeloma by Rajeev Krishnan, Sabna, Bebawy, Mary, Brown, Ross Duncan, Luk, Frederick, Kwan, Yiulam

    Published in Cancer research (Chicago, Ill.) (01-08-2015)
    “…Abstract Introduction: Multiple Myeloma (MM) is an incurable hematological malignancy affecting plasma cells marked by highly heterogeneous survival rates and…”
    Get full text
    Journal Article
  8. 8

    Isolation of Human CD138+ Microparticles from the Plasma of Patients with Multiple Myeloma1 by Krishnan, Sabna Rajeev, Luk, Frederick, Brown, Ross D, Suen, Hayley, Kwan, Yiulam, Bebawy, Mary

    Published in Neoplasia (New York, N.Y.) (21-01-2016)
    “…The confinement of multiple myeloma (MM) to the bone marrow microenvironment requires an invasive bone marrow biopsy to monitor the malignant compartment. The…”
    Get full text
    Journal Article
  9. 9

    Microparticles Isolated from Multiple Myeloma Patients are Indicative of Tumor Burden, Disease Progression and Treatment Unresponsiveness by Krishnan, Sabna Rajeev

    Published 01-01-2016
    “…Multiple Myeloma (MM) is a progressive malignancy of bone-marrow plasma cells. Treatment typically involves combination chemotherapy, which forms part of a…”
    Get full text
    Dissertation